Eric H. Bjerkholt

2011 - Sunesis Pharmaceuticals

In 2011, Eric H. Bjerkholt earned a total compensation of $1.1M as Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals, a 126% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$120,750
Option Awards$654,210
Salary$350,000
Other$3,466
Total$1,128,426

Bjerkholt received $654.2K in option awards, accounting for 58% of the total pay in 2011.

Bjerkholt also received $120.8K in non-equity incentive plan, $350K in salary and $3.5K in other compensation.

Rankings

In 2011, Eric H. Bjerkholt's compensation ranked 5,215th out of 10,747 executives tracked by ExecPay. In other words, Bjerkholt earned more than 51.5% of executives.

ClassificationRankingPercentile
All
5,215
out of 10,747
52nd
Division
Manufacturing
1,890
out of 3,960
52nd
Major group
Chemicals And Allied Products
406
out of 1,038
61st
Industry group
Drugs
253
out of 786
68th
Industry
Pharmaceutical Preparations
199
out of 571
65th
Source: SEC filing on April 25, 2013.

Bjerkholt's colleagues

We found two more compensation records of executives who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2011.

2011

Daniel Swisher

Sunesis Pharmaceuticals

Chief Executive Officer

2011

Steven Ketchum

Sunesis Pharmaceuticals

Former Senior Vice President, Research and Development

News

In-depth

You may also like